Astra's weight-loss programs combine physician-supervised medication, clinical support, and transparent pricing to help eligible patients pursue sustainable metabolic health. We offer compounded semaglutide and tirzepatide as well as brand-name options like Wegovy, Ozempic, Zepbound, and Mounjaro when clinically appropriate. Every patient begins with a secure intake reviewed by a US-licensed provider, followed by prescription fulfillment, home delivery, and ongoing messaging for dose titration, side effects, and lifestyle integration. Treatment is available across all 50 states and is designed for adults with obesity or overweight with weight-related conditions.
Astra's weight-loss category includes compounded GLP-1 programs (semaglutide from $68/mo, tirzepatide from $118/mo) alongside brand-name Wegovy, Ozempic, and Zepbound.
Each program is evaluated and titrated by US-licensed physicians. All plans include provider messaging, supplies, and coordinated pharmacy shipping.